small molecule

TEPADINA

THIOTEPA

Loss of exclusivity—loss of exclusivity

CompanyADIENNE SA

Drug detail

Brand name	TEPADINA
Active ingredient	THIOTEPA
Strength	15MG/VIAL
Dosage form	POWDER
Route	INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Modality	Small molecule
FDA approval	January 2017
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.